Porton Fine Chemicals Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Porton Fine Chemicals Ltd with three other
companies in this sector in China:
Huaren Pharmaceutical Co Ltd
sales of 1.25 billion Chinese Renmimbi [US$197.15 million]
of which 80%
was Medicine Industry),
Fuan Pharmaceutical Group Co Ltd
(1.30 billion Chinese Renmimbi [US$204.73 million]
of which 100%
was Pharmaceutical Industry), and
Shandong Jincheng Pharmaceutical Group Co Ltd
(1.42 billion Chinese Renmimbi [US$224.21 million]
of which 85%
was Medicine Manufacturing).
During the year ended December of 2016, sales at
Porton Fine Chemicals Ltd were 1.33 billion Chinese Renmimbi (US$209.40 million).
increase of 29.9%
versus 2015, when the company's sales were 1.02 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Porton Fine Chemicals Ltd
(and since 2011, sales have increased a total of 140%).
Sales of Other Business saw an increase
that was more than double the company's growth rate: sales were up
106.0% in 2016, from
7.28 million Chinese Renmimbi to 15.00 million Chinese Renmimbi.
Porton Fine Chemicals Ltd also saw significant increases in sales in
Customers Products Business (up 76.6% to 191.55 million Chinese Renmimbi)
Not all segments of Porton Fine Chemicals Ltd experienced an increase in sales in 2016:
sales of Pharmaceutical Chemicals Business Income fell 1.4% to 40.51 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).